Mustafa Noor, T. Seneviratne, F. Aweeka, J. Lo, J. Schwarz, K. Mulligan, M. Schambelan, C. Grunfeld (2002)
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled studyAIDS, 16
D. Haas, C. Zala, S. Schrader, P. Piliero, H. Jaeger, D. Nunes, A. Thiry, S. Schnittman, M. Sension (2003)
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trialAIDS, 17
L. Calza, R. Manfredi, F. Chiodo (2003)
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.The Journal of antimicrobial chemotherapy, 53 1
P. Dowell, C. Flexner, P. Kwiterovich, M. Lane (2000)
Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease Inhibitors*The Journal of Biological Chemistry, 275
Z. Nawaz, B. O’Malley (2004)
Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?Molecular endocrinology, 18 3
J. Zimmermann, D. Erdmann, Isabelle Lalande, Rita Grossenbacher, M. Noorani, P. Fürst (2000)
Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1Oncogene, 19
R. Kaufman, D. Scheuner, M. Schröder, Xiaohua Shen, Kyungho Lee, Chuan-Yin Liu, Stacey Arnold (2002)
The unfolded protein response in nutrient sensing and differentiationNature Reviews Molecular Cell Biology, 3
M. Caron, M. Auclair, H. Sterlingot, M. Kornprobst, J. Capeau (2003)
Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiationAIDS, 17
H. Woerle, P. Mariuz, C. Meyer, R. Reichman, Emilia Popa, J. Dostou, S. Welle, J. Gerich (2003)
Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.Diabetes, 52 4
Yuko Hirano, Minoru Yoshida, M. Shimizu, R. Sato (2001)
Direct Demonstration of Rapid Degradation of Nuclear Sterol Regulatory Element-binding Proteins by the Ubiquitin-Proteasome Pathway*The Journal of Biological Chemistry, 276
P. Hruz, H. Murata, M. Mueckler (2001)
Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism.American journal of physiology. Endocrinology and metabolism, 280 4
Jeffery Cox, R. Chapman, Peter Walter (1997)
The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane.Molecular biology of the cell, 8 9
Thomas Rockel, A. Mikecz (2002)
Proteasome-dependent processing of nuclear proteins is correlated with their subnuclear localization.Journal of structural biology, 140 1-3
M. Johnson, B. Grinsztejn, C. Rodríguez, J. Coco, E. Dejesus, A. Lazzarin, K. Lichtenstein, Anna Rightmire, S. Sankoh, R. Wilber (2005)
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failuresAIDS, 19
Simone Gaedicke, Elke Firat-Geier, O. Constantiniu, Maria Lucchiari-Hartz, M. Freudenberg, C. Galanos, G. Niedermann (2002)
Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.Cancer research, 62 23
K. Squires, A. Lazzarin, J. Gatell, W. Powderly, V. Pokrovskiy, J. Delfraissy, J. Jemsek, A. Rivero, Willy Rozenbaum, S. Schrader, M. Sension, A. Vibhagool, A. Thiry, Michael Giordano (2004)
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 36
YuanXiang Pan, Hong Chen, Fai Siu, M. Kilberg (2003)
Amino Acid Deprivation and Endoplasmic Reticulum Stress Induce Expression of Multiple Activating Transcription Factor-3 mRNA Species That, When Overexpressed in HepG2 Cells, Modulate Transcription by the Human Asparagine Synthetase Promoter*Journal of Biological Chemistry, 278
Fai Siu, P. Bain, Rene LeBlanc-Chaffin, Hong Chen, M. Kilberg (2002)
ATF4 Is a Mediator of the Nutrient-sensing Response Pathway That Activates the Human Asparagine Synthetase Gene*The Journal of Biological Chemistry, 277
R. Wood, P. Phanuphak, P. Cahn, V. Pokrovskiy, W. Rozenbaum, G. Pantaleo, M. Sension, R. Murphy, M. Mancini, T. Kelleher, Michael Giordano (2004)
Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or AtazanavirJAIDS Journal of Acquired Immune Deficiency Syndromes, 36
E. Goetzman, Liqun Tian, T. Nagy, B. Gower, T. Schoeb, A. Elgavish, E. Acosta, M. Saag, P. Wood (2003)
HIV protease inhibitor ritonavir induces lipoatrophy in male mice.AIDS research and human retroviruses, 19 12
P. Cahn, J. Gatell, K. Squires, Lisa Percival, P. Piliero, I. Sanne, Sarah Shelton, A. Lazzarin, Linda Odeshoo, T. Kelleher, A. Thiry, Michael Giordano, S. Schnittman (2004)
Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical TrialsJournal of the International Association of Physicians in AIDS Care, 3
Mustafa Noor, R. Parker, E. O'Mara, D. Grasela, A. Currie, S. Hodder, F. Fiedorek, D. Haas (2004)
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adultsAIDS, 18
K. Rodgers, R. Dean (2003)
Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.The international journal of biochemistry & cell biology, 35 5
(2003)
Proteasome and glucose transport inhibition : a unifying hypothesis for the mechanism of protease inhibitorinduced metabolic disturbances and for the superior lipid profile of atazanavir
J. Hertel, H. Struthers, Christal Horj, P. Hruz (2004)
A Structural Basis for the Acute Effects of HIV Protease Inhibitors on GLUT4 Intrinsic Activity*Journal of Biological Chemistry, 279
G. Werstuck, S. Lentz, S. Dayal, G. Hossain, S. Sood, Yuan-Yuan Shi, Ji Zhou, N. Maeda, S. Krisans, M. Malinow, R. Austin, R. Austin (2001)
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.The Journal of clinical investigation, 107 10
F. Pajonk, Judith Himmelsbach, K. Riess, A. Sommer, W. McBride (2002)
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.Cancer research, 62 18
I. Sanne, P. Piliero, K. Squires, A. Thiry, S. Schnittman (2003)
Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive SubjectsJAIDS Journal of Acquired Immune Deficiency Syndromes, 32
Ying Shen, L. Meunier, L. Hendershot (2002)
Identification and Characterization of a Novel Endoplasmic Reticulum (ER) DnaJ Homologue, Which Stimulates ATPase Activity of BiP in Vitro and Is Induced by ER Stress*The Journal of Biological Chemistry, 277
Jun-shan Liang, O. Distler, D. Cooper, H. Jamil, R. Deckelbaum, H. Ginsberg, S. Sturley (2001)
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemiaNature Medicine, 7
J. Purnell, A. Zambon, R. Knopp, D. Pizzuti, R. Achari, J. Leonard, C. Locke, J. Brunzell (2000)
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjectsAIDS, 14
D. Nolan, S. Mallal (2004)
The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.Journal of HIV therapy, 9 2
Hao Jiang, S. Wek, Barbara Mcgrath, D. Lu, Tsonwin Hai, H. Harding, Xiaozhong Wang, D. Ron, D. Cavener, R. Wek (2004)
Activating Transcription Factor 3 Is Integral to the Eukaryotic Initiation Factor 2 Kinase Stress ResponseMolecular and Cellular Biology, 24
R. Murphy, I. Sanne, P. Cahn, P. Phanuphak, Lisa Percival, T. Kelleher, Michael Giordano (2003)
Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week resultsAIDS, 17
G. Haerter, B. Manfras, Markus Mueller, P. Kern, A. Trein (2004)
Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavirAIDS, 18
Kevin Travers, C. Patil, L. Wodicka, D. Lockhart, J. Weissman, P. Walter (2000)
Functional and Genomic Analyses Reveal an Essential Coordination between the Unfolded Protein Response and ER-Associated DegradationCell, 101
Umut Özcan, Qiong Cao, E. Yilmaz, Ann-Hwee Lee, N. Iwakoshi, Esra Özdelen, Gurol Tuncman, Cem Görgün, L. Glimcher, G. Hotamışlıgil (2004)
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 DiabetesScience, 306
H. Murata, P. Hruz, M. Mueckler (2000)
The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy*The Journal of Biological Chemistry, 275
A. Carr (2000)
HIV protease inhibitor-related lipodystrophy syndrome.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 Suppl 2
J. Lenhard, D. Croom, J. Weiel, D. Winegar (2000)
HIV Protease Inhibitors Stimulate Hepatic Triglyceride SynthesisArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 20
G. Schmidtke, Hermann-Georg Holzhütter, M. Bogyo, N. Kairies, M. Groll, R. Giuli, Sabine Emch, M. Groettrup (1999)
How an Inhibitor of the HIV-I Protease Modulates Proteasome Activity*The Journal of Biological Chemistry, 274
D. Hui (2003)
Effects of HIV protease inhibitor therapy on lipid metabolism.Progress in lipid research, 42 2
Tara Riddle, D. Kuhel, L. Woollett, C. Fichtenbaum, D. Hui (2001)
HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the Nucleus*The Journal of Biological Chemistry, 276
D. Ito, J. Walker, C. Thompson, I. Moroz, William Lin, M. Veselits, A. Hakim, A. Fienberg, G. Thinakaran (2004)
Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective PropertiesMolecular and Cellular Biology, 24
Molecular Pharmacology – Pubmed
Published: Jul 14, 2005
Access the full text.
Sign up today, get DeepDyve free for 14 days.